Schizophrenia News and Research

Latest Schizophrenia News and Research

Autism Speaks awards more than $600,000 to scientists pursuing training in translational research

Autism Speaks, the world's leading autism science and advocacy organization, today announced it has awarded more than $600,000 in funding for six promising scientists pursuing academic training in translational research.

28 Jun 2014

Researchers give new, unprecedented 3-D view of most important brain receptors

Researchers with Oregon Health & Science University's Vollum Institute have given science a new and unprecedented 3-D view of one of the most important receptors in the brain - a receptor that allows us to learn and remember, and whose dysfunction is involved in a wide range of neurological diseases and conditions, including Alzheimer's, Parkinson's, schizophrenia and depression.

28 Jun 2014

Janssen seeks expanded approval of VELCADE from EU for Mantle Cell Lymphoma

Janssen-Cilag International NV today announced its submission of a type II variation to the European Medicines Agency to expand the label for VELCADE (bortezomib) to include its use, in combination with rituximab, cyclophosphamide, doxorubicin and prednisone, for the treatment of adult patients with previously untreated Mantle Cell Lymphoma (MCL).

28 Jun 2014

Insight has ‘trait-like properties’ in psychosis

Poor insight persists in many patients after their first episode of psychosis and is predicted by insight at baseline, report researchers.

26 Jun 2014

Henry Ford launches clinical trial for treatment of tinnitus caused by noise trauma

Henry Ford Health System has launched a clinical trial to investigate a new drug for the treatment of tinnitus, a chronic ringing of the head or ears that affects more than 600 million people worldwide.

25 Jun 2014

University of Maryland School of Medicine receives NIH grant to establish neuroscience research center

The University of Maryland School of Medicine's Maryland Psychiatric Research Center, a research center in the School's Department of Psychiatry, was awarded a $10.7 million grant from the National Institutes of Health to establish a Silvio O. Conte Neuroscience Research Center that will examine the causes of schizophrenia and search for possible new treatments.

25 Jun 2014

New study finds genetic links between schizophrenia risk and cannabis use

Genes that increase the risk of developing schizophrenia may also increase the likelihood of using cannabis, according to a new study led by King's College London, published today in Molecular Psychiatry.

25 Jun 2014

Research roundup: Improving colon cancer screening; disparities in heart care; Medicaid expansion's effect on cities

This report estimated the effect of the Affordable Care Act (ACA) on 14 large and diverse cities: Los Angeles, Chicago, Houston, Philadelphia, Phoenix, Indianapolis, Columbus, Charlotte, Detroit, Memphis, Seattle, Denver, Atlanta, and Miami.

21 Jun 2014

Schizophrenia focus narrowed to dentate gyrus

The dentate gyrus is a likely site of pathology underlying schizophrenia, shows a study published in Molecular Psychiatry.

19 Jun 2014

CBT reduces urge to obey command hallucinations

The COMMAND trial shows that cognitive behaviour therapy can bring about a “clinically meaningful” reduction in the rate at which patients comply with command hallucinations.

19 Jun 2014

Alkermes reports data from aripiprazole lauroxil phase 3 clinical trial for treatment of schizophrenia

Alkermes plc today announced the presentation of data from its phase 3 clinical trial of aripiprazole lauroxil, an investigational drug candidate in development for schizophrenia, at the American Society of Clinical Psychopharmacology Annual Meeting in Hollywood, Fla.

18 Jun 2014

Moving during childhood linked to increased schizophrenia risk

Childhood residential mobility is associated with an increased risk of psychotic disorders, particularly schizophrenia, during adulthood, according to results of a study conducted in Denmark.

16 Jun 2014

Brain structure linked to psychosis symptoms

A study of patients across the psychosis spectrum supports an association between brain structure and psychosis symptoms.

11 Jun 2014

Study presents oxytocin as latest treatment target for age-related muscle wasting

Researchers at the University of California, Berkeley, have discovered that oxytocin -- a hormone associated with maternal nurturing, social attachments, childbirth and sex -- is indispensable for healthy muscle maintenance and repair, and that in mice, it declines with age.

11 Jun 2014

Alkermes initiates FORWARD-3 and FORWARD-4 efficacy studies in pivotal clinical program for ALKS 5461

Alkermes plc today announced the initiation of FORWARD-3 and FORWARD-4, two of the three planned phase 3 core efficacy studies in the pivotal clinical program for ALKS 5461, a once-daily, oral investigational medicine with a novel mechanism of action for the adjunctive treatment of major depressive disorder (MDD).

10 Jun 2014

Kids at risk for mental disorders experience communication breakdown in brain networks

Attention deficits are central to psychiatric disorders such as schizophrenia or bipolar disorder, and are thought to precede the presentation of the illnesses.

9 Jun 2014

Researchers uncover several gene networks with potentially important roles in autism

A large new analysis of DNA from thousands of patients has uncovered several underlying gene networks with potentially important roles in autism.

9 Jun 2014

Gene networks may offer attractive targets for developing new autism drugs

A large new analysis of DNA from thousands of patients has uncovered several underlying gene networks with potentially important roles in autism.

6 Jun 2014

Brain networks supporting attention do not communicate correctly in children at risk for bipolar disorder

Attention deficits are central to psychiatric disorders such as schizophrenia or bipolar disorder, and are thought to precede the presentation of the illnesses.

6 Jun 2014

Brain circuit problem may contribute to auditory hallucinations of schizophrenia

St. Jude Children's Research Hospital scientists have identified problems in a connection between brain structures that may predispose individuals to hearing the "voices" that are a common symptom of schizophrenia. The work appears in the June 6 issue of the journal Science.

6 Jun 2014

Schizophrenia News and Research

Latest Schizophrenia News and Research

Autism Speaks awards more than $600,000 to scientists pursuing training in translational research

Researchers give new, unprecedented 3-D view of most important brain receptors

Janssen seeks expanded approval of VELCADE from EU for Mantle Cell Lymphoma

Insight has ‘trait-like properties’ in psychosis

Henry Ford launches clinical trial for treatment of tinnitus caused by noise trauma

University of Maryland School of Medicine receives NIH grant to establish neuroscience research center

New study finds genetic links between schizophrenia risk and cannabis use

Research roundup: Improving colon cancer screening; disparities in heart care; Medicaid expansion's effect on cities

Schizophrenia focus narrowed to dentate gyrus

CBT reduces urge to obey command hallucinations

Alkermes reports data from aripiprazole lauroxil phase 3 clinical trial for treatment of schizophrenia

Moving during childhood linked to increased schizophrenia risk

Brain structure linked to psychosis symptoms

Study presents oxytocin as latest treatment target for age-related muscle wasting

Alkermes initiates FORWARD-3 and FORWARD-4 efficacy studies in pivotal clinical program for ALKS 5461

Kids at risk for mental disorders experience communication breakdown in brain networks

Researchers uncover several gene networks with potentially important roles in autism

Gene networks may offer attractive targets for developing new autism drugs

Brain networks supporting attention do not communicate correctly in children at risk for bipolar disorder

Brain circuit problem may contribute to auditory hallucinations of schizophrenia

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Schizophrenia News and Research

Latest Schizophrenia News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in